Körner Philipp, Ehrmann Katja, Hartmannsgruber Johann, Metz Michaela, Steigerwald Sabrina, Flentje Michael, van Oorschot Birgitt
Interdisziplinäres Zentrum Palliativmedizin, Universitätsklinikum Würzburg, Josef-Schneider-Str. 2, 97080, Würzburg, Germany.
Klinik und Poliklinik für Strahlentherapie, Universitätsklinikum Würzburg, Würzburg, Germany.
Strahlenther Onkol. 2017 Jul;193(7):570-577. doi: 10.1007/s00066-017-1146-5. Epub 2017 Jun 1.
The benefits of patient-reported symptom assessment combined with integrated palliative care are well documented. This study assessed the symptom burden of palliative and curative-intent radiation oncology patients.
Prior to first consultation and at the end of RT, all adult cancer patients planned to receive fractionated percutaneous radiotherapy (RT) were asked to answer the Edmonton Symptom Assessment Scale (ESAS; nine symptoms from 0 = no symptoms to 10 = worst possible symptoms). Mean values were used for curative vs. palliative and pre-post comparisons, and the clinical relevance was evaluated (symptom values ≥ 4).
Of 163 participating patients, 151 patients (90.9%) completed both surveys (116 curative and 35 palliative patients). Before beginning RT, 88.6% of palliative and 72.3% of curative patients showed at least one clinically relevant symptom. Curative patients most frequently named decreased general wellbeing (38.6%), followed by tiredness (35.0%), anxiety (32.4%), depression (30.0%), pain (26.3%), lack of appetite (23.5%), dyspnea (17.8%), drowsiness (8.0%) and nausea (6.1%). Palliative patients most frequently named decreased general wellbeing (62.8%), followed by pain (62.8%), tiredness (60.0%), lack of appetite (40.0%), anxiety (38.0%), depression (33.3%), dyspnea (28.5%), drowsiness (25.7%) and nausea (14.2%). At the end of RT, the proportion of curative and palliative patients with a clinically relevant symptom had increased significantly to 79.8 and 91.4%, respectively; whereas the proportion of patients reporting clinically relevant pain had decreased significantly (42.8 vs. 62.8%, respectively). Palliative patients had significantly increased tiredness. Curative patients reported significant increases in pain, tiredness, nausea, drowsiness, lack of appetite and restrictions in general wellbeing.
Assessment of patient-reported symptoms was successfully realized in radiation oncology routine. Overall, both groups showed a high symptom burden. The results prove the need of systematic symptom assessment and programs for early integrated supportive and palliative care in radiation oncology.
患者报告的症状评估与综合姑息治疗相结合的益处已有充分记录。本研究评估了姑息性和根治性放疗的肿瘤患者的症状负担。
在首次会诊前及放疗结束时,所有计划接受分次经皮放疗(RT)的成年癌症患者均被要求回答埃德蒙顿症状评估量表(ESAS;9种症状,从0 = 无症状到10 = 最严重症状)。采用平均值进行根治性与姑息性以及放疗前后的比较,并评估临床相关性(症状值≥4)。
163名参与患者中,151名患者(90.9%)完成了两项调查(116名根治性患者和35名姑息性患者)。在开始放疗前,88.6%的姑息性患者和72.3%的根治性患者至少有一项具有临床相关性的症状。根治性患者最常提及的是总体健康状况下降(38.6%),其次是疲劳(35.0%)、焦虑(32.4%)、抑郁(30.0%)、疼痛(26.3%)、食欲不振(23.5%)、呼吸困难(17.8%)、嗜睡(8.0%)和恶心(6.1%)。姑息性患者最常提及的是总体健康状况下降(62.8%),其次是疼痛(62.8%)、疲劳(60.0%)、食欲不振(40.0%)、焦虑(38.0%)、抑郁(33.3%)、呼吸困难(28.5%)、嗜睡(25.7%)和恶心(14.2%)。在放疗结束时,有临床相关性症状的根治性和姑息性患者比例分别显著增加至79.8%和91.4%;而报告有临床相关性疼痛的患者比例显著下降(分别为42.8%和62.8%)。姑息性患者的疲劳感显著增加。根治性患者报告疼痛、疲劳、恶心、嗜睡、食欲不振和总体健康状况受限有显著增加。
在放射肿瘤学常规工作中成功实现了对患者报告症状的评估。总体而言,两组患者的症状负担都很高。结果证明在放射肿瘤学中需要进行系统的症状评估以及早期综合支持和姑息治疗项目。